CONTRAVISORY INVESTMENT MANAGEMENT, INC. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
CONTRAVISORY INVESTMENT MANAGEMENT, INC. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$94,000
-1.1%
2,165
-0.9%
0.03%
+11.1%
Q1 2022$95,000
+28.4%
2,185
+21.5%
0.03%0.0%
Q2 2020$74,000
+7.2%
1,799
-1.9%
0.03%
-12.9%
Q1 2020$69,000
+13.1%
1,834
+40.8%
0.03%
+40.9%
Q4 2019$61,000
+8.9%
1,303
-1.4%
0.02%
+4.8%
Q3 2019$56,000
+9.8%
1,321
+2.7%
0.02%
+5.0%
Q2 2019$51,000
-5.6%
1,2860.0%0.02%
-4.8%
Q1 2019$54,000
+10.2%
1,2860.0%0.02%0.0%
Q4 2018$49,000
+4800.0%
1,286
+7044.4%
0.02%
Q4 2017$1,000180.00%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2022
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 1,282,289$46,483,4037.25%
Columbia Asset Management 9,960$3610.08%
PARK CIRCLE Co 800$29,0000.03%
PARADIGM ASSET MANAGEMENT CO LLC 1,800$65,2500.02%
Byrne Asset Management LLC 56$2,0000.00%
Retirement Group, LLC 40$1,4500.00%
Bartlett & Co. LLC 240$90.00%
HUNTINGTON NATIONAL BANK 1$400.00%
View complete list of GLAXOSMITHKLINE PLC shareholders